MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Multidisciplinary Approach"

  • 2019 International Congress

    Establishing the first apomorphine treatment registry in Thailand: prospective data collection to inform optimal care of Parkinson’s disease patients

    R. Bhidayasiri, O. Phokaewvarangkul, K. Boonpang, T. Boonmongkol, Y. Thongchuam, N. Kantachadvanich, J. Sringean, P. Panyakaew, P. Jagota (Bangkok, Thailand)

    Objective: To establish a registry of PD patients in Thailand treated with subcutaneous apomorphine (APO) injection or infusion to allow prospective data collection from the…
  • 2019 International Congress

    Ancillary Service Utilization and Impact in Huntington’s Disease

    J. Yomtoob, C. Yeh, D. Bega (Chicago, IL, USA)

    Objective: To determine which Huntington’s disease (HD) patient characteristics correlate with ancillary service utilization. To examine the longitudinal impact of ancillary therapies on clinical characteristics.…
  • 2019 International Congress

    Implementation of a Peer-to-Peer Mentoring Intervention for Center of Excellence Coordinators

    C. Hunter, K. Arney, J. Fleisher, P. Palmentera, J. Shurer, F. Cubillos (Houston, TX, USA)

    Objective: Through the Centers of Excellence (COE) network, the Parkinson’s Foundation (PF) unites a community dedicated to improving clinical care in Parkinson’s disease (PD). Each…
  • 2019 International Congress

    Spectrum of motor complications in advanced Parkinson’s disease: data from a large Romanian case series evaluated for suitability for device aided therapy

    J. Szász, V. Constantin, K. Orbán, L. Bancu, D. Georgescu, J. Szederjesi, A. Rácz, I. Mihály, S. Szatmári (Tirgu Mures, Romania)

    Objective: The objective was to describe the spectrum of motor complications in a large cohort of patients with advanced Parkinson’s Disease (APD) who received at…
  • 2019 International Congress

    The development of a patient education and treatment programme for people with Parkinson’s disease

    P. Sloan, J. Farrell, J. Mchattie, L. Ebenezer, H. Evans (Bridgend, United Kingdom)

    Objective: To ensure we have a flexible education and treatment programme format, designed for people with Parkinson's disease (PWP), relevant to their time since diagnosis,…
  • 2019 International Congress

    Results of community pharmacist-led structured medication reviews in Parkinson’s Disease

    N. Oonk, P. Oude Avenhuis, K. Movig, K. Koehorst-Ter Huurne, WH. Nijmeijer, M. van Kesteren-Biegstraaten, J. Vd Palen, L. Dorresteijn (Enschede, Netherlands)

    Objective: To obtain insight in the process of community pharmacist-led structured medication reviews in patients with Parkinson’s disease (PD), by evaluating medication modifications and recommendations, and…
  • 2019 International Congress

    Impairment of Neurological Ontogenesis in Children with Austism Spectrum Disorders

    V. Kozyavkin, T. Voloshyn (Truskavets, Ukraine)

    Objective: To assess level of involvement of neurological impairment in children with Autism Spectrum Disorders (ASD). Background: Autism Spectrum Disorders are not singly related to…
  • 2019 International Congress

    Integrated therapy for Functional Movement Disorders: results from a pilot clinic

    S. Lidstone, L. Macgillivray, C. Marras, M. Josef, L. Muc, A. Lang (Toronto, ON, Canada)

    Objective: To create a novel pilot clinic for the treatment of Functional Movement Disorders (FMD). Background: FMDs are aberrations of motor system functioning in the…
  • 2019 International Congress

    People with Parkinson’s Disease (PPD): disease, stigma and the others

    M. Bacigalupe (La Plata, Argentina)

    Objective: To show what does it mean to be PPD and the relationship with their environment from the point of view of the participants. Background:…
  • 2019 International Congress

    Beliefs, Knowledge and Attitudes Towards Parkinson’s Disease: Turkey Experience from a Global Perspective

    Y. Degirmenci, P. Limousin, GM. Hariz, N. Cakar (Duzce, Turkey)

    Objective: To evaluate the knowledge, attitudes towards disease, and to assess the effect of beliefs on decision making among  patients with PD, and their first-degree…
  • « Previous Page
  • 1
  • …
  • 15
  • 16
  • 17
  • 18
  • 19
  • …
  • 25
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • #23862 (not found)
  • T lymphocytes in Parkinson’s disease pathogenesis and therapy: A systematic review
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley